Back to Search

JOANNE WALDSTREICHER, M.D.

M.D.

Endocrinology, Diabetes & Metabolism Physician

NPI: 1285770826Individual

Specialties, Licenses & Credentials

Endocrinology, Diabetes & Metabolism PhysicianPrimary

Internal Medicine — Endocrinology, Diabetes & Metabolism

Code: 207RE0101X

72263(MA)

Research & Publications (20)

Why is most of the ground brown?
PMID 16830687·Sci Am·2006
8-other
A leg to stand on.
PMID 16018341·Mater Manag Health Care·2005
8-other
A systemic type I 5 alpha-reductase inhibitor is ineffective in the treatment of acne vulgaris.
PMID 14988688·J Am Acad Dermatol·2004
3-trial
Sustained decrease in incidence of acute urinary retention and surgery with finasteride for 6 years in men with benign prostatic hyperplasia.
PMID 14767299·J Urol·2004
3-trial
Effects of finasteride on serum testosterone and body mass index in men with benign prostatic hyperplasia.
PMID 14624915·Urology·2003
3-trial
Long-term 6-year experience with finasteride in patients with benign prostatic hyperplasia.
PMID 12670567·Urology·2003
3-trial
Incidence and severity of sexual adverse experiences in finasteride and placebo-treated men with benign prostatic hyperplasia.
PMID 12639651·Urology·2003
3-trial
Long-term (7 to 8-year) experience with finasteride in men with benign prostatic hyperplasia.
PMID 12475666·Urology·2002
3-trial
Storage (irritative) and voiding (obstructive) symptoms as predictors of benign prostatic hyperplasia progression and related outcomes.
PMID 12121721·Eur Urol·2002
3-trial
Lowering low density lipoprotein cholesterol with simvastatin, a hydroxy-3-methylglutaryl-coenzyme a reductase inhibitor, does not affect luteal function in premenopausal women.
PMID 12107216·J Clin Endocrinol Metab·2002
3-trial
The long-term effect of specific type II 5alpha-reductase inhibition with finasteride on bone mineral density in men: results of a 4-year placebo controlled trial.
PMID 11956450·J Urol·2002
3-trial
Effects of statins on biomarkers of bone metabolism: a randomised trial.
PMID 11434192·Nutr Metab Cardiovasc Dis·2001
3-trial
Comparison of the efficacy and safety of finasteride in older versus younger men with benign prostatic hyperplasia.
PMID 11377309·Urology·2001
3-trial
Androgen antagonists: Potential role in prostate cancer prevention.
PMID 11295597·Urology·2001
8-other
Development of a health-related quality of life questionnaire for women with androgenetic alopecia.
PMID 11167980·Clin Exp Dermatol·2000
8-other
Prostate volume and serum prostate-specific antigen as predictors of acute urinary retention. Combined experience from three large multinational placebo-controlled trials.
PMID 11096237·Eur Urol·2000
3-trial
Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia.
PMID 11050579·J Am Acad Dermatol·2000
3-trial
Impact of baseline symptom severity on future risk of benign prostatic hyperplasia-related outcomes and long-term response to finasteride. The Pless Study Group.
PMID 11018616·Urology·2000
3-trial
Urinary retention in patients with BPH treated with finasteride or placebo over 4 years. Characterization of patients and ultimate outcomes. The PLESS Study Group.
PMID 10765090·Eur Urol·2000
3-trial
Serum prostate specific antigen is a strong predictor of future prostate growth in men with benign prostatic hyperplasia. PROSCAR long-term efficacy and safety study.
PMID 10604304·J Urol·2000
3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
410 GEORGE ST, JOHNSON & JOHNSON
NEW BRUNSWICK, NJ 08901

Location

Practice Location

410 GEORGE ST, NEW BRUNSWICK, NJ
(732) 524-2115

Quick Facts

NPI
1285770826
Entity Type
Individual
Gender
Female
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile